Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07835971
PHASE2

A Study to Evaluate Efficacy and Safety of GW906 in Patients With Essential Hypertension

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the effect of GW906 on systolic and diastolic blood pressure and to characterize the pharmacodynamic (PD) effects and safety of GW906.

Official title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of GW906 (SAL0132) Injection in Patients With Essential Hypertension

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

319

Start Date

2025-12-24

Completion Date

2026-09-15

Last Updated

2026-09-23

Healthy Volunteers

No

Conditions

Interventions

DRUG

GW906

Subcutaneous injection

DRUG

Placebo

Subcutaneous injection

Locations (1)

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China

Shanghai, Shanghai Municipality, China